|
Class 2 Device Recall Accure Laser |
![see related information](../images/related-info.gif) |
Date Initiated by Firm |
December 06, 2023 |
Date Posted |
January 20, 2024 |
Recall Status1 |
Open3, Classified |
Recall Number |
Z-0778-2024 |
Recall Event ID |
93696 |
510(K)Number |
K222109
|
Product Classification |
Powered laser surgical instrument - Product Code GEX
|
Product |
Accure Laser System, Model: PFMS00004 |
Code Information |
UDI-DI: 08059173392230, Serial Numbers:
LAD0000-0004, LAD0000-0014, PROT01-0720, LAD0000-0012, LAD0000-0005, LAD2216-0623, LAD2356-0723, LAD0000-0003, PROTO07-1120, LAD2076-0623, LAD0000-0011, LAD0000-0008, LAD0000-0010, LAD2357-0723, LAD2075-0623, LAD2232-0723, LAD0000-0013, LAD0000-0009, LAD0000-0006, LAD0000-0001, PROT06-1120, LAD2507-0723
|
Recalling Firm/ Manufacturer |
Accure Acne, Inc 4699 Nautilus Ct S Ste 205 Boulder CO 80301-5307
|
Manufacturer Reason for Recall |
Laser system's spot tracking system may become misaligned resulting in the possible risk of delivery of higher-than-expected laser energy to epidermal tissue, which may cause blistering.
|
FDA Determined Cause 2 |
Use error |
Action |
On 12/6/23, "Field Safety Alert(s)" were emailed to customers informing them of the following:
1) Following these steps will minimize the likelihood of Region of Interest (ROI) misalignment:
Make sure that during treatment that the handpiece tip movement is minimized and to not lift off the tip until the emission is complete and foot pedal released. Remember this order of operations to reduce the potential of misalignment:
"Tip down
"Pedal down
"Emission completes
"Pedal up
"Tip up
2) Monitor the patient during treatment for unexpected levels of pain. If higher than usual stop treatment and contact the recalling firm.
3) Immediately discontinue therapy if any Skin Overtemperature alarms are observed while treating with the device in Boost mode. This could be an indication that the ROI is misaligned. Contact your Accure representative before any further use of the device.
4) Immediately discontinue therapy if any PETs are observed that are above the green range displayed on the device touchscreen. This could be an indication that the ROI is misaligned. Contact your recalling firm service representative.
5) Ask your patients to contact you immediately if they experience prolonged erythema (longer than 2 hours) or blistering. Blistering is a potential residual risk and is not expected. If it occurs, it may require medical intervention. It could also be an indication that the ROI is misaligned.
6) If ROI misalignment is suspected suspend all further use of the laser and contact the recalling firm.
The firm is releasing a software upgrade to maintain the ROI in the intended monitored location regardless of movement of the handpiece tip, and will safely detect and disable the system in the event that the ROI has become misaligned.
Acknowledge, and send your response to the firm, see Field Safety Notice. Customers with questions can contact the firm via email at aintintoli@accureacne.com |
Quantity in Commerce |
22 |
Distribution |
US distribution to states of: CO, CA, CT, NY, NJ, MN, LA, OH, MA, TX |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
510(K) Database |
510(K)s with Product Code = GEX and Original Applicant = Accure Acne, Inc.
|
|
|
|